Associate Director Media Excellence at Azurity Pharmaceuticals

Raleigh, North Carolina, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates must possess a BA or BS degree, with an MBA or advanced degree being a plus. A minimum of 6-8 years of experience in pharmaceutical/biotech or life science digital marketing is required, along with at least 5 years in media strategy and planning. Experience working with digital agencies and offshore partners is necessary, as is a deep understanding of DTC and HCP media landscapes, including omnichannel planning and execution. Proven ability to lead cross-functional teams and manage complex projects in a regulated environment, along with strong analytical skills in media performance measurement and optimization, are essential.

Responsibilities

The Associate Director Media Excellence will manage the media agency AOR and oversee a media manager to ensure effective media buying and campaign execution. This role involves leading the development and execution of omnichannel media strategies to achieve brand and corporate goals, while driving innovation and ensuring compliance with pharmaceutical industry regulations. Responsibilities also include analyzing campaign performance to provide actionable insights for optimization and ROI, and partnering with brand teams to support their strategic imperatives and ensure cohesive media content and tactics through collaboration with marketing and PMRC.

Skills

Media Strategy

Media Agency Management

Digital Marketing

Marketing Operations

Omni-channel Engagement

Patient-Centric Marketing

Pharmaceutical Marketing

Azurity Pharmaceuticals

Develops specialized formulations of medicines

About Azurity Pharmaceuticals

Azurity Pharmaceuticals develops specialized formulations of existing medicines to meet the needs of patients who are often overlooked by traditional pharmaceutical companies. Their products include oral suspensions and other forms that are easier to administer, particularly for those who have difficulty swallowing pills or need precise dosing. This focus on creating accessible and effective medications enhances patient compliance and addresses gaps in the pharmaceutical market. Azurity serves healthcare providers, hospitals, and pharmacies, generating revenue through the sale of FDA-approved proprietary medicines across various therapeutic areas, including cardiovascular, central nervous system, and oncology. Their goal is to improve patient outcomes by providing high-quality, innovative medicines tailored to specific medical conditions.

Woburn, MassachusettsHeadquarters

2000Year Founded

$182.2MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

201-500Employees

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Hybrid Work Options

Professional Development Budget

Tuition Reimbursement

Wellness Program

Risks

Product recalls, like Zenzedi's, can damage brand reputation and cause financial losses.

Integration challenges from Slayback Pharma acquisition may disrupt operations.

Reliance on FDA approvals means regulatory delays could impact product launches.

Differentiation

Azurity focuses on innovative dose forms for overlooked patient needs.

Their FDA-approved products ensure safety and efficacy in specialized formulations.

Azurity's acquisition of Slayback Pharma enhances its development and launch capabilities.

Upsides

Growing demand for personalized medicine aligns with Azurity's specialized dose forms.

Increasing chronic diseases boost need for Azurity's innovative drug delivery systems.

FDA's focus on novel formulations benefits Azurity's product pipeline.

Land your dream remote job 3x faster with AI

Try Jobo Free